A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...
Opinion
Tribune Online on MSNOpinion
Applied wisely, genetically modified crops can feed the world —Chinechendo Eze, US-based microbiologist, PhD researcher
Chinechendo Eze is a Nigerian microbiologist and biotechnologist with research focuses on how to genetically engineer crops to enhance growth and resilience. She is a doctoral student and a graduate ...
Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...
AZoLifeSciences on MSN
RNA Modifications Found to Guide Stem Cell Development into Retinal Cells
In a study published in Stem Cell Reports, researchers from the University of Michigan investigated which signals control the ...
DAYTONA BEACH, Fla. — NASCAR today revealed the 2026 NASCAR Whelen Modified Tour schedule, a 16-race slate that blends tradition, competition and fan-favorite venues. “Regional racing has always been ...
With one race remaining on the 2025 NASCAR Whelen Modified Tour schedule, Austin Beers holds a 14-point advantage over Justin Bonsignore in the championship standings. Beers has enjoyed the best ...
This is read by an automated voice. Please report any issues or inconsistencies here. I’ll say this for the promoters of bogus stem cell treatments: They are terrific at finding new ways to market ...
The last time I wrote an article on Sana Biotechnology, Inc. (NASDAQ:SANA), it was in a Seeking Alpha article entitled "Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes ...
Sana Biotechnology, Inc. surged after hedge fund manager Eric Jackson called it a potential "100-bagger" due to its pioneering diabetes cell therapy. Sana Biotechnology's breakthrough islet cell ...
A blood stem cell gene therapy co-developed by UCLA’s Dr. Donald Kohn restored immune function in 59 of 62 children with ADA-SCID, a rare and fatal immune disorder, with no serious complications ...
Once infused back into the patient, the corrected stem cells begin producing healthy immune cells capable of fighting infections. Development of immune cells starts shortly after the gene-modified ...
Once infused back into the patient, the corrected stem cells begin producing healthy immune cells capable of fighting infections. Development of immune cells starts shortly after the gene-modified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback